A carregar cotações...
Previsão
O preço-alvo médio dos analistas é € 8,67 (+70,33%). A mediana é € 8,67 (+70,33%).
| Comprar |
9 |
| Manter |
2 |
| Vender |
1 |
Notícias Ir para o feed de notícias
AdaptHealth appoints Harriss Currie as new CFO
AdaptHealth has appointed Harriss T. Currie as chief financial officer effective Wednesday. He succeeds Jason Clemens, who will oversee the transition until October 1, 2026. Currie served more than 15 years as CFO at Luminex, recently held CFO roles at Health Track Rx and Impulse Dynamics, and most recently was president of the regenerative medicine division at 3D Systems; he holds an MBA from the McCombs School of Business. AdaptHealth provides home healthcare solutions and serves about 4.5 million patients annually across roughly 670 locations in the U.S. » Mais em de.investing.com
AdaptHealth sells diabetes unit to focus on sleep and respiratory growth
AdaptHealth is selling its roughly $600 million diabetes business to Cardinal Health, spinning out e‑commerce operations and exiting certain drop‑ship supply activities to simplify the company and reallocate resources. The company reported 16% Q2 revenue growth but is addressing higher-than-expected service costs in a new West Coast capitated contract and working with its partner to improve economics. Management plans to prioritize organic growth in sleep and respiratory, reduce leverage to about 2.5x, and pursue targeted tuck-in acquisitions while investing in sleep technology and patient digital tools. » Mais em finance.yahoo.com
AdaptHealth cuts full-year guidance after weak Q2 results, shares plunge
AdaptHealth reported a Q2 loss of $1.07 per share versus an expected $0.15 and revenue of $740.3 million, about $106.5 million below analyst forecasts. The company sharply lowered full-year sales guidance to $2.85–2.89 billion (previously $3.45–3.52 billion) and trimmed adjusted EBITDA to $490–520 million from $680–730 million, while reducing free cash flow targets. Shares fell about 47% during the week following the results and guidance revision, raising concerns about the company’s near-term recovery. » Mais em finance.yahoo.com
Dados financeiros da empresa
| (EUR) | junho de 2026 | |
|---|---|---|
| Receitas | 648,66 mi | 29,19% |
| Ganho bruto | 91,31 mi | 299,65% |
| Ganho líquido | -117,35 mi | 1.042,59% |
| EBITDA | -14,18 mi | 110,69% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 714,57 mi |
Número de ações | 136,05 mi |
Máximo/mínimo de 52 semanas | € 11,64 - € 4,52 |
| Dividendos | Não |
Beta | 1,39 |
PER (PE Ratio) | -3,61 |
PEG (PEG Ratio) | 0,12 |
P/VC (PB Ratio) | 0,60 |
P/V (PS Ratio) | 0,27 |
Perfil da empresa
AdaptHealth Corp. bietet zusammen mit seinen Tochtergesellschaften in den Vereinigten Staaten medizinische Geräte für den Heimgebrauch, medizinischen Bedarf sowie häusliche und damit verbundene Dienstleistungen an. Das Unternehmen bietet Schlaftherapiegeräte, Verbrauchsmaterialien und damit verbundene Dienstleistungen an, wie CPAP- und Bi-PAP-Dienste für Personen, die an obstruktiver Schlafapnoe leiden; medizinische Geräte und Verbrauchsmaterialien, einschließlich kontinuierlicher Glukosemonitore und Insulinpumpen für Patienten zur Behandlung von Diabetes; HME für Patienten, die aus der Akutversorgung und anderen Einrichtungen entlassen werden; Sauerstoff und damit verbundene chronische Therapiedienstleistungen für zu Hause; und andere HME-Geräte und Verbrauchsmaterialien für chronisch kranke Patienten mit Wundversorgung, urologischer Versorgung, Inkontinenz, Stoma und Ernährungsbedarf. Das Unternehmen betreut Patienten, die von Medicare, Medicaid und kommerziellen Versicherungen bezahlt werden. Der Hauptsitz von AdaptHealth Corp. befindet sich in Plymouth Meeting, Pennsylvania.
| Nome | ADAPTHEALTH CORP.DL-,0001 |
| CEO | Suzanne Foster |
| Sede | Conshohocken,
pa EUA |
| Site | |
| Setor | Cuidados de saúde |
| Indústria | Cuidados de saúde: prestadores e serviços |
| Entrada em bolsa | 31/05/2018 |
| Colaboradores | 10.900 |
Análise aprofundada
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
NASDAQ | AHCO |